martes, 26 de mayo de 2020

Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers | Journal of Experimental & Clinical Cancer Research | Full Text

Extended half-life target module for sustainable UniCAR T-cell treatment of STn-expressing cancers | Journal of Experimental & Clinical Cancer Research | Full Text

Adapter chimeric antigen receptor (CAR) approaches have emerged has promising strategies to increase clinical safety of CAR T-cell therapy. In the UniCAR system, the safety switch is controlled via a target mo...
Authors:Liliana R. Loureiro, Anja Feldmann, Ralf Bergmann, Stefanie Koristka, Nicole Berndt, Domokos Máthé, Nikolett Hegedüs, Krisztián Szigeti, Paula A. Videira, Michael Bachmann and Claudia Arndt
Citation:Journal of Experimental & Clinical Cancer Research 2020 39:77
Content type:Research
Published on: 

No hay comentarios:

Publicar un comentario